Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immediate and Longitudinal Outcomes of a National Hands-On Basic Research Course in Rhinology.

Laryngoscope investigative otolaryngology·2026
Same author

Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.

Cancer research communications·2026
Same author

Long-term functional and nutritional outcomes in patients with retropharyngeal lymph node-positive hypopharyngeal cancer treated with concurrent chemoradiotherapy.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Secretory carcinoma in the parotid gland: A case report.

Molecular and clinical oncology·2026
Same author

Prevalence of birch pollinosis and oral allergy syndrome in the general population of Hokkaido, Japan.

Auris, nasus, larynx·2026
Same author

Squamous Cell Carcinoma of the External Auditory Canal in a Patient with Netherton Syndrome.

Case reports in dermatology·2026

Related Experiment Video

Updated: Jun 13, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Basic and Clinical Evidence for Perioperative Immunotherapy in Resectable HNSCC.

Shota Sakaue1, Michihisa Kono1, Takumi Kumai1,2

  • 1Department of Otolaryngology Head & Neck Surgery, Asahikawa Medical University, Midorigaoka-Higashi 2-1-1-1, Asahikawa 078-8510, Japan.

Cancers
|June 12, 2026
PubMed
Summary

Perioperative immunotherapy shows promise for resectable head and neck squamous cell carcinoma (HNSCC). While neoadjuvant and adjuvant strategies differ, recent trials support integrating immune checkpoint inhibitors (ICIs) for improved outcomes.

Keywords:
KEYNOTE-689NIVOPOSTOPPD-1head and neck squamous cell carcinomaimmune checkpoint inhibitorperioperative immunotherapy

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Related Experiment Videos

Last Updated: Jun 13, 2026

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies
13:37

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
07:59

Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma

Published on: April 3, 2026

Area of Science:

  • Oncology
  • Immunology
  • Surgical Oncology

Background:

  • Perioperative immunotherapy is a novel approach for resectable head and neck squamous cell carcinoma (HNSCC).
  • The biological basis, clinical efficacy, and optimal use of this strategy require further elucidation.

Purpose of the Study:

  • To review the current literature on perioperative immune checkpoint inhibitor (ICI) therapy in resectable HNSCC.
  • To analyze the immunological effects of surgery, lymph nodes, and treatment timing.

Main Methods:

  • Narrative literature review.
  • Integration of preclinical and clinical evidence.
  • Focus on immunological impact and treatment sequencing.

Main Results:

  • Neoadjuvant immunotherapy primes T-cells and forms immune memory; adjuvant immunotherapy targets residual disease.
  • Early trials confirm safety and pathological responses to perioperative ICIs.
  • Phase III trials (KEYNOTE-689, NIVOPOSTOP) demonstrate improved event-free survival and outcomes in select HNSCC patients.

Conclusions:

  • Perioperative immunotherapy is a viable strategy for resectable HNSCC.
  • Further research is needed for patient selection, biomarker development, and treatment sequencing.